Growth Metrics

Quest Diagnostics (DGX) Total Non-Current Liabilities (2016 - 2026)

Quest Diagnostics' Total Non-Current Liabilities history spans 18 years, with the latest figure at $8.3 billion for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 4.64% to $8.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $8.3 billion, a 4.64% increase, with the full-year FY2025 number at $8.1 billion, down 3.62% from a year prior.
  • Total Non-Current Liabilities hit $8.3 billion in Q1 2026 for Quest Diagnostics, up from $8.1 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for DGX hit a ceiling of $8.4 billion in Q4 2024 and a floor of $5.9 billion in Q1 2023.
  • Historically, Total Non-Current Liabilities has averaged $7.1 billion across 5 years, with a median of $7.0 billion in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: decreased 6.17% in 2023 and later skyrocketed 36.09% in 2024.
  • Tracing DGX's Total Non-Current Liabilities over 5 years: stood at $6.1 billion in 2022, then grew by 11.63% to $6.8 billion in 2023, then increased by 23.49% to $8.4 billion in 2024, then decreased by 3.62% to $8.1 billion in 2025, then grew by 2.31% to $8.3 billion in 2026.
  • Business Quant data shows Total Non-Current Liabilities for DGX at $8.3 billion in Q1 2026, $8.1 billion in Q4 2025, and $8.0 billion in Q3 2025.